These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20921535)

  • 1. Zinc-induced copper deficiency in Wilson disease.
    Horvath J; Beris P; Giostra E; Martin PY; Burkhard PR
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1410-1. PubMed ID: 20921535
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.
    Cortese A; Zangaglia R; Lozza A; Piccolo G; Pacchetti C
    Mov Disord; 2011 Jun; 26(7):1361-2. PubMed ID: 21449011
    [No Abstract]   [Full Text] [Related]  

  • 4. Copper deficiency in Wilson's disease: an avoidable complication of treatment.
    da Silva-Júnior FP; Lucato LT; Machado AA; Barbosa ER
    Mov Disord; 2011 Nov; 26(13):2448-9; author reply 2449-50. PubMed ID: 21956703
    [No Abstract]   [Full Text] [Related]  

  • 5. Wilson disease: copper deficiency and iatrogenic neurological complications with zinc therapy.
    Wu LM; Ekladious A; Wheeler L; Mohamad AA
    Intern Med J; 2020 Jan; 50(1):121-123. PubMed ID: 31943611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
    Dzieżyc K; Litwin T; Sobańska A; Członkowska A
    Neurol Neurochir Pol; 2014; 48(3):214-8. PubMed ID: 24981187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up study on the therapeutic efficacy in 80 children with Wilson disease].
    Xie XW; Li T
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):398-400. PubMed ID: 20497654
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
    Li T; Lin R; Du S; Qu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):19-21. PubMed ID: 9949235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper deficiency myeloneuropathy in a patient with Wilson disease.
    da Silva-Júnior FP; Machado AA; Lucato LT; Cançado EL; Barbosa ER
    Neurology; 2011 May; 76(19):1673-4. PubMed ID: 21555737
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined zinc sulphate and NSAID-induced gastric ulcer perforation in Wilson disease: A case report.
    Gilbert A; Doussot A; Lagoutte N; Facy O; Cheynel N; Rat P
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):e11-2. PubMed ID: 26601640
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
    Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
    Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease.
    Mizuochi T; Kimura A; Shimizu N; Nishiura H; Matsushita M; Yoshino M
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):365-7. PubMed ID: 21970993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early occurrence of hypertransaminasemia in a 13-month-old child with Wilson disease.
    Iorio R; D'Ambrosi M; Mazzarella G; Varrella F; Vecchione R; Vegnente A
    J Pediatr Gastroenterol Nutr; 2003 May; 36(5):637-8. PubMed ID: 12717088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Copper removal using zinc].
    Hoogenraad TU
    Ned Tijdschr Geneeskd; 1985 Mar; 129(12):529-32. PubMed ID: 3990838
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy.
    Brewer GJ; Johnson V; Dick RD; Kluin KJ; Fink JK; Brunberg JA
    Arch Neurol; 1996 Oct; 53(10):1017-25. PubMed ID: 8859064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
    Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
    Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of zinc sulfate in the treatment of Wilson's disease].
    Jonderko G; Pluta H; Wieczorek U
    Pol Tyg Lek; 1988 Apr; 43(14):459-60. PubMed ID: 3412983
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of the laboratory determination of low serum copper in adults.
    Kumar N; Butz JA; Burritt MF
    Clin Chem Lab Med; 2007; 45(10):1402-10. PubMed ID: 17727313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
    Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.